Orion Corporation Release: The Androgen Receptor Inhibitor ODM-201 - New Insights In The Treatment Of Prostate Cancer
2/3/2014 9:07:00 AM
ESPOO, Finland, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Three posters on ODM-201 from two clinical trials (ARADES and ARAFOR), reviewing pharmacokinetic, safety and efficacy data were presented at the ASCO Genitourinary Cancers Symposium (Jan 30-2 Feb 2014) in San Francisco.
Help employers find you! Check out all the jobs and post your resume.
comments powered by